JP2022518148A5 - - Google Patents
Info
- Publication number
- JP2022518148A5 JP2022518148A5 JP2021539166A JP2021539166A JP2022518148A5 JP 2022518148 A5 JP2022518148 A5 JP 2022518148A5 JP 2021539166 A JP2021539166 A JP 2021539166A JP 2021539166 A JP2021539166 A JP 2021539166A JP 2022518148 A5 JP2022518148 A5 JP 2022518148A5
- Authority
- JP
- Japan
- Prior art keywords
- pyrimidine
- methylbenzofl
- carboxylic acid
- pyrrolidine
- optionally substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962788624P | 2019-01-04 | 2019-01-04 | |
| US62/788,624 | 2019-01-04 | ||
| PCT/US2020/012243 WO2020142729A1 (en) | 2019-01-04 | 2020-01-03 | Inhibitors of cgas activity as therapeutic agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022518148A JP2022518148A (ja) | 2022-03-14 |
| JP2022518148A5 true JP2022518148A5 (cg-RX-API-DMAC7.html) | 2023-03-06 |
| JP7507161B2 JP7507161B2 (ja) | 2024-06-27 |
Family
ID=72338800
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021539166A Active JP7507161B2 (ja) | 2019-01-04 | 2020-01-03 | 治療薬としてのcGAS活性の阻害剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220073532A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3906241A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7507161B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20210112316A (cg-RX-API-DMAC7.html) |
| CN (1) | CN113302194A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020205114A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3125625A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020142729A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4216940A4 (en) * | 2020-09-24 | 2025-01-01 | Ventus Therapeutics U.S., Inc. | PYRIDO[4,3-B INDOLE DERIVATIVES AND THEIR USE AS MEDICAMENTS |
| CN116997339A (zh) * | 2021-02-11 | 2023-11-03 | 贝尔布鲁克实验室有限责任公司 | 作为治疗剂的cGAS活性抑制剂 |
| BR112023020381A2 (pt) | 2021-05-12 | 2023-11-21 | Boehringer Ingelheim Int | Derivados de piridina com substituintes cíclicos ligados por c como inibidores de cgas |
| CN117337292A (zh) * | 2021-05-12 | 2024-01-02 | 勃林格殷格翰国际有限公司 | 作为cGAS抑制剂的具有N-连接环状取代基的吡啶衍生物 |
| CN117337291A (zh) * | 2021-05-12 | 2024-01-02 | 勃林格殷格翰国际有限公司 | 作为cGAS抑制剂的具有C-连接环状取代基的吡啶衍生物 |
| WO2024035622A1 (en) * | 2022-08-10 | 2024-02-15 | Bellbrook Labs, Llc | INHIBITORS OF cGAS ACTIVITY AS THERAPEUTIC AGENTS |
| CA3267076A1 (en) * | 2022-11-09 | 2024-05-16 | Boehringer Ingelheim International Gmbh | CYCLIC PYRIDINE DERIVATIVES USED AS CGAS INHIBITORS |
| CN121248633A (zh) * | 2022-11-09 | 2026-01-02 | 勃林格殷格翰国际有限公司 | 作为cGAS抑制剂的环状苯并咪唑衍生物 |
| US20250257076A1 (en) | 2024-02-14 | 2025-08-14 | Janssen Pharmaceutica Nv | SUBSTITUTED PYRROLIDINE-2-CARBOXYLIC ACID DERIVATIVES AS cGAS INHIBITORS |
| WO2025233174A1 (en) | 2024-05-08 | 2025-11-13 | Boehringer Ingelheim International Gmbh | Benzimidazole derivatives as cgas inhibitors |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3755583A (en) * | 1970-06-05 | 1973-08-28 | Chas0!nhx | |
| DE10348023A1 (de) * | 2003-10-15 | 2005-05-19 | Imtm Gmbh | Neue Alanyl-Aminopeptidasen-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen |
| EP1812113A1 (en) * | 2004-11-11 | 2007-08-01 | Argenta Discovery Limited | Pyrimidine compounds as histamine modulators |
| EP1767537A1 (en) | 2005-09-21 | 2007-03-28 | Cellzome (UK) Ltd. | Pyrimidine compounds for the treatment of inflammatory disorders |
| ES2441958T3 (es) * | 2006-07-11 | 2014-02-07 | Janssen Pharmaceutica Nv | Moduladores de benzofuro- y benzotienopirimidina del receptor de histamina H4 |
| AU2008345225A1 (en) * | 2007-12-21 | 2009-07-09 | University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
| GB2465405A (en) * | 2008-11-10 | 2010-05-19 | Univ Basel | Triazine, pyrimidine and pyridine analogues and their use in therapy |
| WO2013115167A1 (ja) | 2012-01-31 | 2013-08-08 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | アムバチニブ誘導体 |
| CN104513258B (zh) * | 2013-09-26 | 2018-04-03 | 广东东阳光药业有限公司 | 取代脲衍生物及其在药物中的应用 |
| KR20250065420A (ko) * | 2015-12-25 | 2025-05-12 | 가부시키가이샤 한도오따이 에네루기 켄큐쇼 | 화합물, 발광 소자, 표시 장치, 전자 기기, 및 조명 장치 |
| EP3700527A4 (en) * | 2017-10-25 | 2021-03-10 | Children's Medical Center Corporation | PAPD5 INHIBITORS AND METHOD OF USING THEM |
-
2020
- 2020-01-03 WO PCT/US2020/012243 patent/WO2020142729A1/en not_active Ceased
- 2020-01-03 CA CA3125625A patent/CA3125625A1/en active Pending
- 2020-01-03 KR KR1020217020729A patent/KR20210112316A/ko not_active Withdrawn
- 2020-01-03 JP JP2021539166A patent/JP7507161B2/ja active Active
- 2020-01-03 US US17/419,833 patent/US20220073532A1/en not_active Abandoned
- 2020-01-03 EP EP20736080.1A patent/EP3906241A4/en not_active Withdrawn
- 2020-01-03 CN CN202080007945.XA patent/CN113302194A/zh active Pending
- 2020-01-03 AU AU2020205114A patent/AU2020205114A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7317878B2 (ja) | 多環式tlr7/8アンタゴニスト及び免疫障害の治療におけるそれらの使用 | |
| JP6505013B2 (ja) | スルファモイル−アリールアミド及びb型肝炎の治療のための薬剤としてのその使用 | |
| JP4724665B2 (ja) | キノリノン化合物を合成する方法 | |
| JP6517928B2 (ja) | キナーゼ阻害剤として有用なインドールカルボキシアミド | |
| JP2024506904A5 (cg-RX-API-DMAC7.html) | ||
| TWI583681B (zh) | 胺基嘧啶基化合物 | |
| CN109641906B (zh) | 杂芳基取代的氨基吡啶化合物 | |
| CN114787150A (zh) | 炔基喹唑啉化合物 | |
| JP2021534124A5 (cg-RX-API-DMAC7.html) | ||
| JP2010506854A5 (cg-RX-API-DMAC7.html) | ||
| TW201925187A (zh) | 經碸吡啶烷基醯胺取代之雜芳基化合物 | |
| JP2012503018A5 (cg-RX-API-DMAC7.html) | ||
| JP2007510668A5 (cg-RX-API-DMAC7.html) | ||
| JP2018514544A5 (cg-RX-API-DMAC7.html) | ||
| CN115485026A (zh) | Nlrp3炎体途径抑制剂吡唑并[1,2-d][1,2,4]三嗪-2-基-乙酰胺 | |
| JP2016527238A5 (cg-RX-API-DMAC7.html) | ||
| JP2005530722A5 (cg-RX-API-DMAC7.html) | ||
| WO2008064116A2 (en) | Method of preventing or treating organ, hematopoietic stem cell or bone marrow transplant rejection | |
| CA2682649A1 (en) | Imidazolidine carboxamide derivatives as p2x7 modulators | |
| CA2557271A1 (en) | 1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors | |
| JP2023554442A (ja) | 新規キナゾリノン誘導体 | |
| TR201901074T4 (tr) | MGlu2 reseptörlerinin negatif allosterik modülatörleri olarak 6,7-dihidropirazolo[1,5-a]pirazin-4(5h)-on bileşikleri ve bunların kullanımı. | |
| JP2021536505A5 (cg-RX-API-DMAC7.html) | ||
| JP2013542267A5 (cg-RX-API-DMAC7.html) | ||
| JP2017534569A5 (cg-RX-API-DMAC7.html) |